Published in Clin Genet on November 23, 2009
Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer. Support Care Cancer (2012) 0.89
Health professionals' evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer. Fam Cancer (2015) 0.80
'Sifting the significance from the data' - the impact of high-throughput genomic technologies on human genetics and health care. Hum Genomics (2012) 0.75
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2001) 1.51
Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. Am J Hum Genet (1997) 1.50
'I can't do any serious exercise': barriers to physical activity amongst people of Pakistani and Indian origin with Type 2 diabetes. Health Educ Res (2005) 1.46
Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer. J Clin Oncol (2000) 1.45
Investigating genetic discrimination in Australia: a large-scale survey of clinical genetics clients. Clin Genet (2008) 1.37
A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students. J Med Genet (2003) 1.37
Family Communication and Genetic Counseling: The Case of Hereditary Breast and Ovarian Cancer. J Genet Couns (1997) 1.34
Attentional bias to threat: roles of trait anxiety, stressful events, and awareness. Q J Exp Psychol A (1994) 1.31
Stratified cancer screening: the practicalities of implementation. Public Health Genomics (2013) 1.11
Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes. Br J Cancer (2004) 1.07
Sorting nexin 3 (SNX3) is disrupted in a patient with a translocation t(6;13)(q21;q12) and microcephaly, microphthalmia, ectrodactyly, prognathism (MMEP) phenotype. J Med Genet (2002) 1.02
Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer. Patient Educ Couns (2001) 1.01
Diabetes service provision: a qualitative study of the experiences and views of Pakistani and Indian patients with Type 2 diabetes. Diabet Med (2006) 0.97
Genetic research on rare familial disorders: consent and the blurred boundaries between clinical service and research. J Med Ethics (2008) 0.93
Microsatellite instability markers in breast cancer: a review and study showing MSI was not detected at 'BAT 25' and 'BAT 26' microsatellite markers in early-onset breast cancer. Breast Cancer Res Treat (2000) 0.91
There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer. Gynecol Oncol (2011) 0.87
'Start the conversation': the New South Wales (Australia) family health history campaign. Public Health Genomics (2009) 0.87
Psychological impact of preimplantation genetic diagnosis: a review of the literature. Reprod Biomed Online (2009) 0.87
Counseling families with hereditary breast and ovarian cancer: A psychosocial perspective. J Genet Couns (1995) 0.86
A prospective study assessing anxiety, depression and maternal-fetal attachment in women using PGD. Hum Reprod (2010) 0.86
Attitudes to genetic testing for breast cancer susceptibility in women at increased risk developing hereditary breast cancer. J Med Genet (2000) 0.86
Cultural aspects of cancer genetics: setting a research agenda. J Med Genet (2001) 0.86
Surveillance or surgery? A description of the factors that influence high risk premenopausal women's decisions about prophylactic oophorectomy. J Med Genet (2001) 0.86
Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Gynecol Oncol (1999) 0.84
Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriers. Fam Cancer (2005) 0.83
Participants' experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4-T) trial: qualitative interview study. Diabet Med (2011) 0.83
Familial neuronal intranuclear inclusion disease with ubiquitin positive inclusions. J Neurol Sci (1998) 0.82
Women's experience of pre-implantation genetic diagnosis: a qualitative study. Prenat Diagn (2010) 0.82
Issues faced by unaffected men with a family history of prostate cancer: a multidisciplinary overview. J Urol (2008) 0.79
"Sporadic" motoneuron disease due to familial SOD1 mutation with low penetrance. Lancet (1995) 0.78
Melanoma survivors at high risk of developing new primary disease: a qualitative examination of the factors that contribute to patient satisfaction with clinical care. Psychooncology (2013) 0.78
Psychological adjustment, knowledge and unmet information needs in women undergoing PGD. Hum Reprod (2010) 0.77
Providing letters to patients. Patients find summary letters useful. BMJ (1998) 0.76
Estimation of an approximate confidence interval for FRAXA location by using linkage data from many pedigrees. Am J Hum Genet (1991) 0.75
Genetic testing: a round table conversation. Intern Med J (2004) 0.75
The impact of molecular diagnosis on familial colorectal cancer. Clin Chem Lab Med (1998) 0.75
A comparison of community, clinician, and patient preferences for naming a cancer-related mutation. Clin Genet (2007) 0.75
Management of MUTYH-associated neoplasia in Australia. Intern Med J (2008) 0.75
Genetic Counseling, Reproductive Behavior and Future Reproductive Intentions of People with Neurofibromatosis Type 1 (NF1). J Genet Couns (1998) 0.75
Consumers' views on ethical issues in genetics. J Genet Couns (1998) 0.75